Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV rapid tests: progress, perspective, and future directions.

Joe Burrage1

  • 1burragej@uab.edu

Clinical Journal of Oncology Nursing
|April 17, 2003
PubMed
Summary

The U.S. Food and Drug Administration approved the OraQuick Rapid HIV-1 Antibody Test for faster results. This reliable test detects HIV-1 antibodies using a simple finger stick blood sample, providing results in 20 minutes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A methylome-wide association study of major depression with out-of-sample case-control classification and trans-ancestry comparison.

Nature. Mental health·2025
Same author

Cell-type-specific DNA methylation dynamics in the prenatal and postnatal human cortex.

Cell genomics·2025
Same author

Guidance for the design and analysis of cell-type-specific DNA methylation epidemiology studies.

Briefings in bioinformatics·2025
Same author

Setd1a Loss-of-function Disrupts Epigenetic Regulation of Ribosomal Genes via Altered DNA Methylation.

Schizophrenia bulletin·2025
Same author

Methylomic signature of current cannabis use in two first-episode psychosis cohorts.

Molecular psychiatry·2024
Same author

Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts.

Translational psychiatry·2024

Area of Science:

  • Medical Diagnostics
  • Infectious Disease Research
  • Public Health

Background:

  • Traditional HIV testing methods often require venipuncture and longer processing times.
  • The need for rapid and accessible HIV-1 antibody detection is crucial for timely intervention.
  • Advancements in diagnostic technology aim to improve patient experience and speed of results.

Purpose of the Study:

  • To introduce the OraQuick Rapid HIV-1 Antibody Test, recently approved by the FDA.
  • To highlight the advantages of the OraQuick test over conventional HIV testing techniques.
  • To discuss the practical implications and future potential of this rapid diagnostic technology.

Main Methods:

  • The study focuses on the U.S. Food and Drug Administration's approval of the OraQuick Rapid HIV-1 Antibody Test.
  • The test utilizes a finger-stick blood sample, a departure from traditional venipuncture.
  • The diagnostic process is designed to yield results within a 20-minute timeframe.

Main Results:

  • The OraQuick Rapid HIV-1 Antibody Test received FDA approval in November 2002.
  • The test demonstrates reliability in detecting HIV-1 antibodies.
  • Results are available rapidly, within 20 minutes, from a finger-stick sample.

Conclusions:

  • The OraQuick test offers a reliable and rapid method for HIV-1 antibody detection.
  • Its use of finger-stick blood simplifies sample collection compared to venipuncture.
  • This technology has significant implications for clinical practice and future HIV diagnostics.

Related Experiment Videos